Global Drug Discovery Informatics Market Hits $3,525.7 Million in 2025 with 8.2% CAGR

global Drug discovery informatics market was valued at $3,525.7 million in 2025 and is projected to reach $7,682.1 million by 2035, growing at a CAGR of 8.2% during the forecast period (2026-2035). Drug discovery informatics encompasses the use of advanced computational tools, software platforms, databases, and analytics to accelerate and optimize the drug development lifecycle from target identification and lead optimization to preclinical and clinical research. Key solution areas include cheminformatics, bioinformatics, pharmacoinformatic, molecular modeling, AI-driven drug design, and data management platforms. The market is witnessing steady global expansion driven by rising R&D investments by pharmaceutical and biotechnology companies, increasing complexity of biological data, and the urgent need to reduce drug development time and costs. The growing adoption of AI, machine learning, cloud computing, and big data analytics is transforming traditional discovery workflows, enabling predictive modeling, virtual screening, and data-driven decision-making.

Browse the full report description of “Drug Discovery Informatics Market Size, Share & Trends Analysis Report by Function (Docking, Molecular Modeling, Libraries & Database Preparation, Sequencing & Target Data Analysis, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Others) Forecast Period, (2026-2035)” at https://www.omrglobal.com/industry-reports/drug-discovery-informatics-market

According to National Library of Medicine (NLM), the rapid expansion of publicly accessible biomedical databases and computational resources has significantly strengthened the role of informatics across drug discovery and development. Open chemical, genomic, and bioassay datasets maintained by NLM and its partner institutions are now foundational to molecular modeling, docking, sequencing analysis, and data-driven target identification.

Key Innovators Driving Drug Discovery Informatics Transformation

The key players in the drug discovery informatics market include Dassault Systèmes SE, Clarivate plc, Illumina, Inc, Schrödinger, Inc, Thermo Fisher Scientific Inc., among others. are at the forefront of innovation, offering advanced platforms for molecular modeling, simulation, data integration, AI-powered analytics, and end-to-end discovery workflows. Their solutions are enabling researchers to make faster, data-driven decisions and improve the probability of clinical success.

• In October 2025, Schrödinger, Inc. expanded its AI-powered drug discovery platform by introducing advanced physics-based and machine learning models designed to improve predictive accuracy in molecular simulations. The enhanced platform enables researchers to identify high-quality drug candidates faster, reduce late-stage failures, and improve R&D productivity, reinforcing the role of informatics as a critical pillar of modern drug discovery.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Function
  • By End-Users
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Dassault Systèmes SE, Clarivate plc, Illumina, Inc, Schrödinger, Inc, Thermo Fisher Scientific Inc., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Drug Discovery Informatics Market Report Segment

By Function

• Docking
• Molecular Modeling
• Libraries & Database Preparation
• Sequencing & Target Data Analysis
• Others

By End-Users

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Others

Global Drug Discovery Informatics Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/drug-discovery-informatics-market